SCHEMBL8191007

SCHEMBL8191007

CCCc1cccc(CNC(N)=O)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.49
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
ALDH1A1 P00352 2/20 0.45
HPGD P15428 1/20 0.45
GRIN2D O15399 1/20 0.44
GRIN3B O60391 1/20 0.44
GRIN1 Q05586 1/20 0.44
GRIN2A Q12879 1/20 0.44
GRIN2B Q13224 1/20 0.44
GRIN2C Q14957 1/20 0.44
GRIN3A Q8TCU5 1/20 0.44
SIGMAR1 Q99720 1/20 0.44
NOS2 P35228 1/20 0.44
POLB P06746 2/20 0.43
ESR1 P03372 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
MTNR1A P48039 1/20 0.43
MTNR1B P49286 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8513394 0.88 RECQL (0.59) RECQLCYP2C9CYP2C19ALDH1A1HPGD
SCHEMBL8191596 0.86 RECQL (0.51) RECQLCYP2C9CYP2C19ALDH1A1HPGD
SCHEMBL19361212 0.83 NOS1 (0.46) ALDH1A1HPGDGRIN2DGRIN3BGRIN1
SCHEMBL21556932 0.83 GRIN2D (0.44) ALDH1A1HPGDGRIN2DGRIN3BGRIN1
SCHEMBL24325174 0.82 CYP2C9 (0.61) RECQLCYP2C9CYP2C19ALDH1A1HPGD
SCHEMBL7041171 0.81 CYP2C9 (0.58) RECQLCYP2C9CYP2C19ALDH1A1HPGD
SCHEMBL20041617 0.80 RECQL (0.49) RECQLCYP2C9CYP2C19ALDH1A1HPGD
SCHEMBL5527522 0.79 KDM4E (0.61) RECQLCYP2C9CYP2C19ALDH1A1HPGD
SCHEMBL8180636 0.79 RECQL (0.47) RECQLCYP2C9CYP2C19ALDH1A1HPGD
SCHEMBL14470273 0.78 RECQL (0.44) RECQLCYP2C9CYP2C19ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008063669-A1 HETEROBICYCLIC MATRIX METALLOPROTEASE INHIBITORS ALANTOS PHARMACEUTICALS HOLDING, INC. (US) 2008-05-29 WO disclosed
WO-2008063671-A2 HETEROBICYCLIC METALLOPROTEASE INHIBITORS ALANTOS PHARMACEUTICALS HOLDING, INC. (US) 2008-05-29 WO disclosed
WO-2008002671-A2 METALLOPROTEASE INHIBITORS ALANTOS PHARMACEUTICALS HOLDING, INC. (US) 2008-01-03 WO disclosed
WO-2007079199-A2 SUBSTITUTED BIS-AMIDE METALLOPROTEASE INHIBITORS ALANTOS PHARMACEUTICALS, HOLDING, INC. (US) 2007-07-12 WO disclosed
WO-2006128184-A2 PYRIMIDINE OR TRIAZINE FUSED BICYCLIC METALLOPROTEASE INHIBITORS ALANTOS-PHARMACEUTICALS, INC. (US) 2006-11-30 WO disclosed